Compliance Rate
Compliance Rate
47.06%
Compliant submissions
8
Incompliant submissions
9
Total trials
17
My Organizations' Clinical Trials
Showing 50 of 867 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 06/01/10
End: 09/01/16
Due: 09/01/17
Phase: N/A
Priority: Normal
Start: 03/31/15
End: 09/30/20
Due: 09/30/21
Phase: N/A
Priority: Normal
Start: 10/17/24
End: 07/31/28
Due: 07/31/29
Phase: N/A
Priority: Normal
Start: 02/28/10
End: 01/31/12
Due: 01/31/13
Phase: N/A
Priority: Normal
Start: 07/31/08
End: 07/31/09
Due: 07/31/10
Phase: N/A
Priority: Normal
Start: 05/03/24
End: 06/30/26
Due: 06/30/27
Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer
Phase: N/A
Priority: Normal
Start: 12/13/13
End: 08/01/20
Due: 08/01/21
Phase: N/A
Priority: Normal
Start: 08/19/22
End: 10/01/27
Due: 10/01/28
Phase: N/A
Priority: Normal
Start: 11/30/20
End: 12/01/24
Due: 12/01/25
Phase: N/A
Priority: Normal
Start: 02/23/18
End: 04/10/19
Due: 04/10/20
Phase: N/A
Priority: Normal
Start: 02/13/23
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 10/31/14
End: 01/31/17
Due: 01/31/18
Phase: N/A
Priority: Normal
Start: 12/05/11
End: 03/31/18
Due: 03/31/19
Phase: N/A
Priority: Normal
Start: 04/30/09
End: 06/30/11
Due: 06/30/12
Phase: N/A
Priority: Normal
Start: 09/23/24
End: 09/30/25
Due: 09/30/26
Phase: N/A
Priority: Normal
Start: 03/31/10
End: 11/30/15
Due: 11/30/16
Phase: N/A
Priority: Normal
Start: 11/01/20
End: 04/01/26
Due: 04/01/27
Phase: N/A
Priority: Normal
Start: 03/26/15
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 01/25/24
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 03/31/16
End: 09/15/17
Due: 09/15/18
Phase: N/A
Priority: Normal
Start: 10/10/18
End: 07/20/22
Due: 07/20/23
Phase: N/A
Priority: Normal
Start: 07/21/20
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 06/01/21
End: 07/12/23
Due: 07/12/24